- Home
- AVDL
as 11-22-2024 4:00pm EST
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
| Founded: | 2015 | Country: | Ireland |
| Employees: | N/A | City: | DUBLIN |
| Market Cap: | 1.4B | IPO Year: | 1996 |
| Target Price: | $24.00 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.41 - $19.09 | Next Earning Date: | 11-12-2024 |
| Revenue: | $138,160,000 | Revenue Growth: | 1523.50% |
| Revenue Growth (this year): | 533.23% | Revenue Growth (next year): | 73.08% |
Latest Avadel Pharmaceuticals plc News
AVDL Breaking Stock News: Dive into AVDL Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
UBS Adjusts Price Target on Avadel Pharmaceuticals to $22 From $25, Maintains Buy Rating
Simply Wall St.
11 days ago
Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
GlobeNewswire
12 days ago
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
GuruFocus.com
12 days ago
Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ...
MT Newswires
13 days ago
Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises
Associated Press Finance
13 days ago
Avadel: Q3 Earnings Snapshot
GlobeNewswire
13 days ago
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results
GuruFocus.com
14 days ago
Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings
Compare AVDL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AVDL Avadel Pharmaceuticals plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.